Healthcare Equipment and Supplies
Company Overview of nContact, Inc.
nContact, Inc. is an ablation company that engages in the development of arrhythmia and cardiovascular disease management programs for cardiac arrhythmias. The company offers ablation system devices to ensure consistent and predictable contact with cardiac tissue during the creation of linear lesions. Its solutions include EPi-Sense devices with embedded electrodes that allow for sensing and navigation of the epicardium; EPi-Sense Guided Coagulation Device with VisiTrax that integrates suction, perfusion, and RF energy to ensure cardiac tissue contact and energy transmission to create linear lesions on a beating heart; The Cannula that allows surgeons direct visualization while ablating on t...
1001 Aviation Parkway
Morrisville, NC 27560
Founded in 2004
Key Executives for nContact, Inc.
Co-Founder and Vice President of Research & Clinicals
Co-Founder and Vice President of Development & Operations
Vice President of Finance
Compensation as of Fiscal Year 2015.
nContact, Inc. Key Developments
nContact, Inc. Presents at 18th Annual Needham Growth Conference, Jan-14-2016 02:10 PM
Dec 24 15
nContact, Inc. Presents at 18th Annual Needham Growth Conference, Jan-14-2016 02:10 PM. Venue: Lotte New York Palace Hotel, New York, New York, United States.
AtriCure, Inc., nContact, Inc. - M&A Call
Oct 5 15
To discuss AtriCure definitive agreement to acquire nContact
nContact Appoints William Hawkins as Chairman of its Board of Directors
Jul 21 15
nContact announced that William (Bill) Hawkins has been appointed as Chairman of its Board of Directors. Bill Hawkins has served as a special advisor to the nContact Board since 2013 and is a veteran entrepreneur and executive in the medical device arena, with more than 20 years of C-Suite experience in cardiology, surgery, and vascular therapies. Most recently, Bill was President and CEO of Immucor.
Similar Private Companies By Industry
Recent Private Companies Transactions
October 4, 2015
Most Searched Private Companies
Sponsored Financial Commentaries